|
2005 Archive |
|
|
|
|
|
Biotech Monthly newsletter |
|
| December 2005 -
36 pgs. Main Story: Neurochem (NRMX) |
|
|
|
| November 2005 -
47 pgs. Main Story: YM Biosciences (AMEX:YMI) |
|
|
|
| October 2005 -
25 pgs. Main Story: Alzheimer's Disease |
|
|
|
| September 2005 -
31 pgs. Main Story: Cypress Bioscience (CYPB) |
|
|
|
| August 2005 -
157
pgs.
Biotech Monthly Fourth Annual
Anniversary Issue |
|
| If you are
interested in biotech, you cannot miss this issue. 157 pages
detailing the outlook for all 21 companies in our
coverage universe. Our most popular issue and considered by some to
be the "handbook" for biotech investing for the second half of
the year. Also available for single-issue purchase. |
|
|
|
| July 2005 -
30 pgs. Main Story: Zadaxin Partly Unmasked (SciClone-SCLN) |
|
|
|
| June 2005 -
32 pgs. Main Story: Oncolytics Biotech (ONCY) |
|
|
|
| May 2005 -
30
pgs. Main Story: A crisis in clinical trials |
|
|
|
| April 2005 -
42 pgs. Main Story: ASCO Preview |
|
|
|
| March 2005 -
45
pgs. Main Story: Scanning the biotech sector for potential deals |
|
|
|
| February 2005 -
26
pgs. Main Stories: Biotech Primer: Management & Biotech Short
Interest |
|
|
|
| January 2005 -
30
pgs. Main Story: Structural changes in the markets affect
biotech sector |
|
|
|
| BSR
Alerts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04/13/2005 - 3:00am EDT |
Dendreon |
| |
